MetaCurUm’s cancer strategy backed by scientific Letter on liquid biomarkers
A research team from Umeå and Uppsala university led by Maréne Landström, founder of UBI-supported MetaCurUm Biotech, has identified a panel of seven blood-based protein biomarkers that can accurately detect clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer.